HI-Bio

Human Immunology Biosciences (HI-Bio)

This biotechnology company develops targeted immunotherapies for patients with rare, severe immune-mediated diseases, such as chronic kidney conditions and antibody-mediated transplant rejection.

Hillstar Bio

This biotechnology company develops precision immunology therapies that target and deplete pathogenic immune cells for patients with autoimmune diseases.

Clim Bio

This biotechnology company develops antibody-based medicines for patients with immune-mediated diseases such as lupus and IgA nephropathy.

Ouro Medicines

This biotechnology firm develops T-cell engager therapies to treat patients living with chronic immune-mediated diseases.

Evommune

This biotechnology company develops medicinal therapies to treat patients suffering from chronic inflammatory and immune-mediated diseases.

Beeline Medicines

This clinical-stage biotechnology company develops precision therapies for patients living with autoimmune and inflammatory diseases.

Attovia Therapeutics

The company develops biparatopic biologics to treat patients with immune-mediated diseases and cancer through a modular protein design platform.

Granite Bio

This clinical-stage biotechnology company develops therapeutic antibodies to treat patients with inflammatory, autoimmune and fibrotic diseases.